Ginkgo Bioworks (NYSE:DNA) Stock Price Expected to Rise, BTIG Research Analyst Says

Ginkgo Bioworks (NYSE:DNA – Get Free Report) had its target price increased by BTIG Research from $6.00 to $9.00 in a report released on Monday, Marketbeat reports. The firm currently has a “sell” rating on the stock. BTIG Research’s target price suggests a potential downside of 29.57% from the company’s current price. Separately, Cowen reissued […]

Leave a Reply

Your email address will not be published.

Previous post Lucky Strike Entertainment (LUCK) to Release Earnings on Thursday
Next post Barclays Upgrades FirstEnergy (NYSE:FE) to “Overweight”